Shruti Chaturvedi

3.6k total citations
101 papers, 2.0k citations indexed

About

Shruti Chaturvedi is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Shruti Chaturvedi has authored 101 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 51 papers in Immunology and 34 papers in Genetics. Recurrent topics in Shruti Chaturvedi's work include Complement system in diseases (50 papers), Renal Diseases and Glomerulopathies (25 papers) and Platelet Disorders and Treatments (24 papers). Shruti Chaturvedi is often cited by papers focused on Complement system in diseases (50 papers), Renal Diseases and Glomerulopathies (25 papers) and Platelet Disorders and Treatments (24 papers). Shruti Chaturvedi collaborates with scholars based in United States, India and Canada. Shruti Chaturvedi's co-authors include Keith R. McCrae, Robert A. Brodsky, Evan M. Braunstein, Michael R. DeBaun, Xuan Yuan, Jia Yu, Hang Chen, Donald M. Arnold, Kathryn Dane and Alison R. Moliterno and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Shruti Chaturvedi

83 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shruti Chaturvedi United States 24 899 769 505 463 380 101 2.0k
Mehdi Khellaf France 26 1.6k 1.8× 292 0.4× 609 1.2× 245 0.5× 177 0.5× 73 2.3k
Xinping Tian China 27 398 0.4× 774 1.0× 164 0.3× 1.6k 3.4× 268 0.7× 214 2.8k
Peter Mollee Australia 25 841 0.9× 300 0.4× 444 0.9× 134 0.3× 273 0.7× 180 2.5k
Elena Baldissera Italy 23 274 0.3× 601 0.8× 110 0.2× 656 1.4× 305 0.8× 65 2.0k
Tom Cairns United Kingdom 26 376 0.4× 493 0.6× 353 0.7× 506 1.1× 821 2.2× 59 2.3k
Agnès Veyradier France 31 1.8k 2.0× 2.4k 3.1× 962 1.9× 87 0.2× 1.3k 3.4× 108 3.3k
Gülen Hatemi Türkiye 31 482 0.5× 433 0.6× 175 0.3× 1.8k 4.0× 105 0.3× 189 4.1k
Javier Cabiedes Mexico 25 712 0.8× 527 0.7× 148 0.3× 1.8k 3.9× 202 0.5× 60 2.3k
Nicolas Limal France 20 670 0.7× 283 0.4× 248 0.5× 376 0.8× 164 0.4× 47 1.5k
Vicente Rodríguez‐Valverde Spain 26 522 0.6× 660 0.9× 521 1.0× 2.0k 4.4× 327 0.9× 67 3.2k

Countries citing papers authored by Shruti Chaturvedi

Since Specialization
Citations

This map shows the geographic impact of Shruti Chaturvedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shruti Chaturvedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shruti Chaturvedi more than expected).

Fields of papers citing papers by Shruti Chaturvedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shruti Chaturvedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shruti Chaturvedi. The network helps show where Shruti Chaturvedi may publish in the future.

Co-authorship network of co-authors of Shruti Chaturvedi

This figure shows the co-authorship network connecting the top 25 collaborators of Shruti Chaturvedi. A scholar is included among the top collaborators of Shruti Chaturvedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shruti Chaturvedi. Shruti Chaturvedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sullivan, Sean D., et al.. (2025). Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States.. PubMed. 31(3). 277–288. 1 indexed citations
2.
Yu, Jia, Gloria F. Gerber, Michael B. Streiff, et al.. (2025). Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP. Blood Advances. 9(23). 5945–5953.
3.
Gómez-Bañuelos, Eduardo, Shruti Chaturvedi, Fabrizio Conti, et al.. (2025). Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE. Annals of the Rheumatic Diseases. 84(9). 1501–1511. 1 indexed citations
4.
Yanek, Lisa R., et al.. (2025). VWF:ADAMTS13 ratio is associated with white matter hyperintensity. Blood. 146(Supplement 1). 739–739.
5.
6.
7.
Cole, Michael, Gloria F. Gerber, George McNamara, et al.. (2024). Complement biosensors identify a classical pathway stimulus in complement-mediated thrombotic microangiopathy. Blood. 144(24). 2528–2545. 7 indexed citations
8.
9.
Karantanos, Theodoros, Donna M. Williams, Shruti Chaturvedi, et al.. (2023). Characterization of myeloproliferative neoplasms in the paediatric and young adult population. British Journal of Haematology. 201(3). 449–458. 11 indexed citations
10.
Chaturvedi, Shruti, et al.. (2023). Idiopathic Multicentric Castleman Disease Results in Endothelium Activation and Coagulation Dysregulation Via Tissue Factor and PAI-1. Blood. 142(Supplement 1). 5414–5414. 1 indexed citations
11.
Kasthuri, Raj S., Shruti Chaturvedi, Sachdev Thomas, et al.. (2022). Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument. Blood Advances. 6(14). 4301–4309. 1 indexed citations
12.
Yu, Jia, Xuan Yuan, Hang Chen, et al.. (2020). Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood. 136(18). 2080–2089. 249 indexed citations
13.
Yuan, Xuan, Jia Yu, Gloria F. Gerber, et al.. (2020). Ex vivo assays to detect complement activation in complementopathies. Clinical Immunology. 221. 108616–108616. 10 indexed citations
14.
Mazepa, Marshall, Camila Masias, & Shruti Chaturvedi. (2019). How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns. Blood. 134(5). 415–420. 31 indexed citations
15.
Chaturvedi, Shruti, Donald M. Arnold, & Keith R. McCrae. (2018). Splenectomy for immune thrombocytopenia: down but not out. Blood. 131(11). 1172–1182. 131 indexed citations
16.
Chaturvedi, Shruti & Keith R. McCrae. (2017). Diagnosis and management of the antiphospholipid syndrome. Blood Reviews. 31(6). 406–417. 121 indexed citations
17.
Chaturvedi, Shruti, et al.. (2017). Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey. Thrombosis Research. 153. 14–18. 19 indexed citations
18.
Chaturvedi, Shruti, Olalekan O. Oluwole, Spero R. Cataland, & Keith R. McCrae. (2017). Post-traumatic stress disorder and depression in survivors of thrombotic thrombocytopenic purpura. Thrombosis Research. 151. 51–56. 32 indexed citations
19.
Garcia, J. & Shruti Chaturvedi. (2014). Novel agents in the management of castration resistant prostate cancer. Journal of Carcinogenesis. 13(1). 5–5. 18 indexed citations
20.
Chaturvedi, Shruti, Erin Cockrell, Ricardo Espinola, et al.. (2014). Circulating microparticles in patients with antiphospholipid antibodies: Characterization and associations. Thrombosis Research. 135(1). 102–108. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mehdi Khellaf Breakdown of academic impact, for papers by Xinping Tian Breakdown of academic impact, for papers by Peter Mollee Breakdown of academic impact, for papers by Elena Baldissera Breakdown of academic impact, for papers by Tom Cairns Breakdown of academic impact, for papers by Agnès Veyradier Breakdown of academic impact, for papers by Gülen Hatemi Breakdown of academic impact, for papers by Javier Cabiedes Breakdown of academic impact, for papers by Nicolas Limal Breakdown of academic impact, for papers by Vicente Rodríguez‐Valverde
Rankless by CCL
2026